Chongqing Pharscin’s Gabexate Mesylate Passes GQCE as First Generic in China
China-based Chongqing Pharscin Pharmaceutical Co., Ltd (SHE: 002907) announced that its gabexate mesylate has passed...
GQCE testing
Hybio Pharmaceutical’s Liraglutide Filing Accepted by NMPA, Becomes Domestic Leader in GLP-1 Analog
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) announced that its market filing for liraglutide, a...
CDE Releases 61st Batch of Generic Reference Preparations, 34 New Specs Added
The Center for Drug Evaluation (CDE) has released the 61st batch of chemical generic reference...
NMPA Releases 56th Batch of GQCE Reference Drugs, Including 14 Injectables
The National Medical Products Administration (NMPA) has released the 56th batch of reference drugs for...
NMPA Releases 55th Batch of Reference Drugs for Generic Evaluation
The National Medical Products Administration (NMPA) has released the 55th batch of reference drugs for...
CDE Releases 58th and 59th Batches of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 58th and 59th batches of chemical...